The Protective Effect of Maternal Folic Acid Supplementation on Childhood Cancer: A Systematic Review and Meta-analysis of Case-control Studies

Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi
Wan Rosmawati Wan IsmailAzmawati Mohammed Nawi

Abstract

Maternal folic acid supplementation is considered mandatory in almost every country in the world to prevent congenital malformations. However, little is known about the association of maternal folic acid intake with the occurrence of childhood cancer. Hence, this study aimed to determine the effects of maternal folic acid consumption on the risk of childhood cancer. A total of 158 related articles were obtained from PubMed, Google Scholar, Scopus, and ProQuest using standardized keywords, of which 17 were included in the final review. Eleven of the 17 articles showed a significant protective association between maternal folic acid supplementation and childhood cancer. Using a random-effects model, pooled odds ratios (ORs) showed a protective association between maternal folic acid supplementation and childhood acute lymphoblastic leukaemia (OR, 0.75; 95% confidence interval [CI], 0.66 to 0.86). However, there was no significant association between maternal folic acid supplementation and acute myeloid leukaemia (OR, 0.70; 95% CI, 0.46 to 1.06) or childhood brain tumours (OR, 1.02; 95% CI, 0.88 to 1.19). Maternal folic acid supplementation was found to have a protective effect against childhood acute lymphoblastic leukaemia. Thus...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Oct 8, 1999·American Journal of Epidemiology·M M WerlerA A Mitchell
Nov 24, 1999·The New England Journal of Medicine·L D BottoJ D Erickson
Dec 6, 2003·The Oncologist·Lynn A Gloeckler RiesBrenda K Edwards
Nov 9, 2004·The American Journal of Clinical Nutrition·Young-In Kim
Dec 4, 2004·Cancer Causes & Control : CCC·Amanda K ShawHoward I Morrison
Feb 23, 2007·Clinical Pharmacology and Therapeutics·Y I GohG Koren
Mar 9, 2007·European Journal of Pediatrics·Joachim SchüzPeter Kaatsch
Sep 17, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kimberly J JohnsonXiao Ou Shu
Oct 20, 2009·International Journal of Cancer. Journal International Du Cancer·Elizabeth MilneBruce K Armstrong
May 12, 2010·Journal of Clinical Pharmacology·Sandy G GruppGideon Koren
May 25, 2010·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Juan Antonio Ortega-GarcíaJuan Francisco Martínez-Lage
Jun 1, 2010·Cancer Epidemiology·Karin StålbergHelle Kieler
Aug 11, 2010·Plastic and Reconstructive Surgery·Jae W Song, Kevin C Chung
Oct 28, 2010·British Journal of Cancer·A M LinaberyUNKNOWN Children's Oncology Group
Feb 7, 2012·Neuro-oncology·Elizabeth FordLesley Fallowfield
Mar 24, 2012·The Journal of Clinical Endocrinology and Metabolism·Michael F HolickConnie M Weaver
Sep 4, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Elizabeth MilneUNKNOWN Aus-CBT Consortium
Apr 11, 2013·Nature Reviews. Neuroscience·Katherine S ButtonMarcus R Munafò
Aug 20, 2014·Journal of Biomedical Science·Subit BaruaMohammed A Junaid
Jun 14, 2016·Cancer Causes & Control : CCC·Amanda W SingerCatherine Metayer
Jun 29, 2016·Nutrition and Cancer·Efrat Lev AmitayLital Keinan-Boker
Jan 6, 2017·International Journal of Cancer. Journal International Du Cancer·Helen D BaileyJacqueline Clavel
Apr 16, 2017·The Lancet Oncology·Eva Steliarova-FoucherUNKNOWN IICC-3 contributors

❮ Previous
Next ❯

Software Mentioned

PubMed
ProQuest
PICO
Scopus
Google Scholar
Review Manager

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi
Wan Rosmawati Wan IsmailAzmawati Mohammed Nawi
BMJ : British Medical Journal
D MetsonJ Cruise
JAMA : the Journal of the American Medical Association
Arshya Vahabzadeh, Christopher J McDougle
© 2021 Meta ULC. All rights reserved